MORBIDITY AND MORTALITY OUTCOMES FOR PATIENTS WITH MODERATE-TO-SEVERE COVID-19 DISEASES: A POST-HOSPITALIZATION FOLLOW-UP STUDY

Intro: The burden of post-COVID-related morbidity and mortality is significant yet undermined. We studied the morbidity and mortality outcomes of COVID-19 patients with moderate-to-severe diseases by 90-day post-hospitalization. Methods: This retrospective cohort study included 510 COVID-19 patients...

Full description

Bibliographic Details
Main Authors: C.P. Hor, L.K. Teo, H.X. Wang, Y.J. Teoh, T.L. Chong, C.H. Yen, N. Abdul Mutalib, J.T. Cheng
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971223005052
_version_ 1797824492954714112
author C.P. Hor
L.K. Teo
H.X. Wang
Y.J. Teoh
T.L. Chong
C.H. Yen
N. Abdul Mutalib
J.T. Cheng
author_facet C.P. Hor
L.K. Teo
H.X. Wang
Y.J. Teoh
T.L. Chong
C.H. Yen
N. Abdul Mutalib
J.T. Cheng
author_sort C.P. Hor
collection DOAJ
description Intro: The burden of post-COVID-related morbidity and mortality is significant yet undermined. We studied the morbidity and mortality outcomes of COVID-19 patients with moderate-to-severe diseases by 90-day post-hospitalization. Methods: This retrospective cohort study included 510 COVID-19 patients admitted to Kepala Batas Hospital with moderate to severe diseases, requiring oxygen therapy during hospitalization (Malaysia COVID severity category ≥5; WHO scale ≥5), between January and August 2021. We conducted telephone surveillance for 90 days post-discharge from the hospital, assessing for post- COVID complications and mortality. Relevant clinical data were extracted from medical records. Multiple logistic regression was employed to examine factors associated with post-COVID mortality after index hospitalization. Findings: Among 510 patients, 51%(n=260) were male with a mean age of 52.1 (14.65) years. A third had hypertension (39.8%) and diabetes (31.4%). Only 15.5% were partially vaccinated and 4.9% had complete vaccination before hospitalization. Nearly 65% were supplemented with nasal prong or face mask oxygenation (<10L/ min), 25.7% received high flow oxygenation and 10% were mechanically ventilated. Approximately 23.3% (n=119) of patients were admitted to the intensive care unit. By 90-day post-hospitalization, 46% (n=203) reported residual symptoms: lethargy (14.5%), dyspnoea (12.2%), hair loss (7.5%), memory loss (6.3%), depression (3.9%), anxiety (2.7%) and 1.6% required home oxygen supplementation. Forty-four patients (8.5%) were re- hospitalized at least once, with 40.9% due to post-COVID complications. About 87% of patients attended their post-COVID clinic appointment. Nearly 13.5% (n=69) of patients died within 90 days after being discharged from the hospital. Adjusted for gender, comorbids and ventilatory status, age ≥60 years (aOR 7.96; 95%CI 3.75-16.92; p<0.001), diabetes (aOR 2.30; 95%CI 1.12-4.72; p=0.024) and high oxygen requirement (aOR 3.41; 95%CI 1.56-7.46; p=0.002), were associated with increased 90-day post-COVID mortality. Conclusion: Post-COVID morbidity and mortality are significant among survivors hospitalized for moderate- to-sever disease. Comprehensive care must be addressed to improve the outcomes of post-COVID patients.
first_indexed 2024-03-13T10:39:48Z
format Article
id doaj.art-24847dae739a4ed89a0dadbec1bd5a2b
institution Directory Open Access Journal
issn 1201-9712
language English
last_indexed 2024-03-13T10:39:48Z
publishDate 2023-05-01
publisher Elsevier
record_format Article
series International Journal of Infectious Diseases
spelling doaj.art-24847dae739a4ed89a0dadbec1bd5a2b2023-05-18T04:39:12ZengElsevierInternational Journal of Infectious Diseases1201-97122023-05-01130S152S153MORBIDITY AND MORTALITY OUTCOMES FOR PATIENTS WITH MODERATE-TO-SEVERE COVID-19 DISEASES: A POST-HOSPITALIZATION FOLLOW-UP STUDYC.P. Hor0L.K. Teo1H.X. Wang2Y.J. Teoh3T.L. Chong4C.H. Yen5N. Abdul Mutalib6J.T. Cheng7Kepala Batas Hospital, Department of Medicine, Kepala Batas, MalaysiaPulau Pinang Hospital, Clinical Research Centre, George Town, MalaysiaKepala Batas Hospital, Department of Medicine, Kepala Batas, MalaysiaKepala Batas Hospital, Department of Pharmacy, Kepala Batas, MalaysiaKepala Batas Hospital, Department of Medicine, Kepala Batas, MalaysiaQueen Elizabeth II Hospital, Clinical Research Centre, Kota Kinabalu, MalaysiaKepala Batas Hospital, Health Management Unit, Kepala Batas, MalaysiaKepala Batas Hospital, Department of Medicine, Kepala Batas, MalaysiaIntro: The burden of post-COVID-related morbidity and mortality is significant yet undermined. We studied the morbidity and mortality outcomes of COVID-19 patients with moderate-to-severe diseases by 90-day post-hospitalization. Methods: This retrospective cohort study included 510 COVID-19 patients admitted to Kepala Batas Hospital with moderate to severe diseases, requiring oxygen therapy during hospitalization (Malaysia COVID severity category ≥5; WHO scale ≥5), between January and August 2021. We conducted telephone surveillance for 90 days post-discharge from the hospital, assessing for post- COVID complications and mortality. Relevant clinical data were extracted from medical records. Multiple logistic regression was employed to examine factors associated with post-COVID mortality after index hospitalization. Findings: Among 510 patients, 51%(n=260) were male with a mean age of 52.1 (14.65) years. A third had hypertension (39.8%) and diabetes (31.4%). Only 15.5% were partially vaccinated and 4.9% had complete vaccination before hospitalization. Nearly 65% were supplemented with nasal prong or face mask oxygenation (<10L/ min), 25.7% received high flow oxygenation and 10% were mechanically ventilated. Approximately 23.3% (n=119) of patients were admitted to the intensive care unit. By 90-day post-hospitalization, 46% (n=203) reported residual symptoms: lethargy (14.5%), dyspnoea (12.2%), hair loss (7.5%), memory loss (6.3%), depression (3.9%), anxiety (2.7%) and 1.6% required home oxygen supplementation. Forty-four patients (8.5%) were re- hospitalized at least once, with 40.9% due to post-COVID complications. About 87% of patients attended their post-COVID clinic appointment. Nearly 13.5% (n=69) of patients died within 90 days after being discharged from the hospital. Adjusted for gender, comorbids and ventilatory status, age ≥60 years (aOR 7.96; 95%CI 3.75-16.92; p<0.001), diabetes (aOR 2.30; 95%CI 1.12-4.72; p=0.024) and high oxygen requirement (aOR 3.41; 95%CI 1.56-7.46; p=0.002), were associated with increased 90-day post-COVID mortality. Conclusion: Post-COVID morbidity and mortality are significant among survivors hospitalized for moderate- to-sever disease. Comprehensive care must be addressed to improve the outcomes of post-COVID patients.http://www.sciencedirect.com/science/article/pii/S1201971223005052
spellingShingle C.P. Hor
L.K. Teo
H.X. Wang
Y.J. Teoh
T.L. Chong
C.H. Yen
N. Abdul Mutalib
J.T. Cheng
MORBIDITY AND MORTALITY OUTCOMES FOR PATIENTS WITH MODERATE-TO-SEVERE COVID-19 DISEASES: A POST-HOSPITALIZATION FOLLOW-UP STUDY
International Journal of Infectious Diseases
title MORBIDITY AND MORTALITY OUTCOMES FOR PATIENTS WITH MODERATE-TO-SEVERE COVID-19 DISEASES: A POST-HOSPITALIZATION FOLLOW-UP STUDY
title_full MORBIDITY AND MORTALITY OUTCOMES FOR PATIENTS WITH MODERATE-TO-SEVERE COVID-19 DISEASES: A POST-HOSPITALIZATION FOLLOW-UP STUDY
title_fullStr MORBIDITY AND MORTALITY OUTCOMES FOR PATIENTS WITH MODERATE-TO-SEVERE COVID-19 DISEASES: A POST-HOSPITALIZATION FOLLOW-UP STUDY
title_full_unstemmed MORBIDITY AND MORTALITY OUTCOMES FOR PATIENTS WITH MODERATE-TO-SEVERE COVID-19 DISEASES: A POST-HOSPITALIZATION FOLLOW-UP STUDY
title_short MORBIDITY AND MORTALITY OUTCOMES FOR PATIENTS WITH MODERATE-TO-SEVERE COVID-19 DISEASES: A POST-HOSPITALIZATION FOLLOW-UP STUDY
title_sort morbidity and mortality outcomes for patients with moderate to severe covid 19 diseases a post hospitalization follow up study
url http://www.sciencedirect.com/science/article/pii/S1201971223005052
work_keys_str_mv AT cphor morbidityandmortalityoutcomesforpatientswithmoderatetoseverecovid19diseasesaposthospitalizationfollowupstudy
AT lkteo morbidityandmortalityoutcomesforpatientswithmoderatetoseverecovid19diseasesaposthospitalizationfollowupstudy
AT hxwang morbidityandmortalityoutcomesforpatientswithmoderatetoseverecovid19diseasesaposthospitalizationfollowupstudy
AT yjteoh morbidityandmortalityoutcomesforpatientswithmoderatetoseverecovid19diseasesaposthospitalizationfollowupstudy
AT tlchong morbidityandmortalityoutcomesforpatientswithmoderatetoseverecovid19diseasesaposthospitalizationfollowupstudy
AT chyen morbidityandmortalityoutcomesforpatientswithmoderatetoseverecovid19diseasesaposthospitalizationfollowupstudy
AT nabdulmutalib morbidityandmortalityoutcomesforpatientswithmoderatetoseverecovid19diseasesaposthospitalizationfollowupstudy
AT jtcheng morbidityandmortalityoutcomesforpatientswithmoderatetoseverecovid19diseasesaposthospitalizationfollowupstudy